Sutent
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2250 Perimeter Park Dr Ste 300, Morrisvi...Phone Number
(877) 744-5675Website
www.sutent.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sutent
Sutent is a pharmaceutical company that develops and provides SUTENT® (sunitinib malate), a treatment option for advanced kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). The product is prescribed by healthcare professionals to adult patients and has been on the market for over 15 years. Eligible patients can benefit from financial assistance programs to reduce their out-of-pocket costs. The company maintains a commitment to product quality and safety monitoring.Explore more
Sutent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sutent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sutent has new funding data
Check out if Sutent is spiking on competitors!
Sutent, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sutent had a recent Job posting/layoffs
Check if Sutent has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sutent recently announced quarterly report
Product Launch: Get notified when Sutent launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sutent
Recommended Actions
Reach out to Masked Content who joined Sutent as Masked Content
Find more new buyers
Compare Similar Companies to Sutent
Compare insights from companies similar to Sutent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sutent is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sutent is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sutent.
Sutent Tech Stack
A closer look at the technologies used by Sutent
See more technologies
Sutent News & Media
Sutent - API Insight, 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Sutent - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Sutent - API Insight, 2019 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Sutent. The report also highlights the patent details of Sutent. Scope of the Report A comprehensive product overview including product description, reguSutent 2016-2017 U.S Promotional Report - Research and Markets
DUBLIN--(BUSINESS WIRE)--The "Sutent 2016 U.S Promotional Report" report has been added to Research and Markets' offering. The 5 Key Questions Addressed by this Report: How many physicians were reached by Sutent through personal promotion in 2016 and how does this compare to its peer set in the Gastrointestinal Stromal Tumors, Pancreatic Cancer, and Renal Cancer markets? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sutent
Sign Up For FreeTo access detailed company insights
Sutent is a pharmaceutical company that develops and provides SUTENT® (sunitinib malate), a treatment option for advanced kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). The product is prescribed by healthcare professionals to adult patients and has been on the market for over 15 years. Eligible p... Read More
